Leucettinib-21: Safety and Effects Study

We are investigating the safety and effects of Leucettinib-21 in healthy individuals and patients with Down Syndrome and Alzheimer’s. This study aims to understand how the drug works in different populations.

Safety phase (I)Neurology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Eurofins Optimed

Clinical Research

Gières, France

Sponsor: Eurofins Optimed

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.